Literature DB >> 24242044

miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2.

Chaoguang Xin1, Hao Zhang, Zanchao Liu.   

Abstract

MicroRNAs play critical roles in the development and progression of colorectal cancer (CRC). miR-154 acts as a tumor suppressor in several tumors; however, its role in CRC is poorly understood. Herein, we found that miR-154 was decreased in CRC tissues and cell lines. Ectopic expression of miR-154 remarkably suppressed cell proliferation and colony formation, migration and invasion in CRC cells. The toll-like receptor 2 (TLR2) was found to be a direct target of miR-154 in CRC cells. Inhibition of TLR2 performed similar effects with miR-154 overexpression on CRC cells, and overexpression of TLR2 could significantly reverse the tumor suppressive effects of miR-154 on CRC cells. This study suggests an essential role for miR-154 in CRC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24242044     DOI: 10.1007/s11010-013-1892-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

Review 1.  Toll-like receptor regulation of effector T lymphocyte function.

Authors:  Joseph M Reynolds; Chen Dong
Journal:  Trends Immunol       Date:  2013-07-22       Impact factor: 16.687

2.  Species-specific PAMP recognition by TLR2 and evidence for species-restricted interaction with Dectin-1.

Authors:  Sam Willcocks; Victoria Offord; Hans-Martin Seyfert; Tracey J Coffey; Dirk Werling
Journal:  J Leukoc Biol       Date:  2013-06-20       Impact factor: 4.962

3.  Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets.

Authors:  Wenzhang Wang; Bo Peng; Dan Wang; Xiaopin Ma; Deke Jiang; Jing Zhao; Long Yu
Journal:  Int J Cancer       Date:  2011-02-26       Impact factor: 7.396

4.  Association of TLR2, TLR3, TLR4 and CD14 genes polymorphisms with oral cancer risk and survival.

Authors:  K Zeljic; G Supic; N Jovic; R Kozomara; M Brankovic-Magic; M Obrenovic; Z Magic
Journal:  Oral Dis       Date:  2013-06-24       Impact factor: 3.511

5.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

6.  MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.

Authors:  Charalambos C Solomides; Barry J Evans; Jean-Marc Navenot; Rajanikanth Vadigepalli; Stephen C Peiper; Zi-xuan Wang
Journal:  Acta Cytol       Date:  2012-11-24       Impact factor: 2.319

7.  The core microprocessor component DiGeorge syndrome critical region 8 (DGCR8) is a nonspecific RNA-binding protein.

Authors:  Braden M Roth; Daniella Ishimaru; Mirko Hennig
Journal:  J Biol Chem       Date:  2013-07-26       Impact factor: 5.157

8.  Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis.

Authors:  Sunhwa Kim; Hiroyuki Takahashi; Wan-Wan Lin; Pascal Descargues; Sergei Grivennikov; Youngjun Kim; Jun-Li Luo; Michael Karin
Journal:  Nature       Date:  2009-01-01       Impact factor: 49.962

9.  MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.

Authors:  Xu Qian; Jing Yu; Yu Yin; Jun He; Lin Wang; Qi Li; Lou-Qian Zhang; Chong-Yong Li; Zhu-Mei Shi; Qing Xu; Wei Li; Li-Hui Lai; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Cell Cycle       Date:  2013-04-08       Impact factor: 4.534

Review 10.  DAMPening inflammation by modulating TLR signalling.

Authors:  A M Piccinini; K S Midwood
Journal:  Mediators Inflamm       Date:  2010-07-13       Impact factor: 4.711

View more
  26 in total

1.  MicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5.

Authors:  Hui Xu; Dan Fei; Shan Zong; Zhimin Fan
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  MicroRNA-154/ADAM9 axis inhibits the proliferation, migration and invasion of breast cancer cells.

Authors:  Chengwei Qin; Yanming Zhao; Chunzhi Gong; Zhenlin Yang
Journal:  Oncol Lett       Date:  2017-09-21       Impact factor: 2.967

3.  MiR-154 Functions as a Tumor Suppressor in Glioblastoma by Targeting Wnt5a.

Authors:  Dongsheng Zhao; Rencong Wang; Junkang Fang; Xituan Ji; Juan Li; Xiaoyan Chen; Gangfeng Sun; Zhengjun Wang; Weiping Liu; Yangang Wang; Guang Cheng; Haining Zhen; Chunhua Sun; Zhou Fei
Journal:  Mol Neurobiol       Date:  2016-03-25       Impact factor: 5.590

4.  MicroRNA-154 functions as a tumor suppressor in non-small cell lung cancer through directly targeting B-cell-specific Moloney murine leukemia virus insertion site 1.

Authors:  Sida Liu; Yang Yang; Lu Chen; Danwei Liu; Han Dong
Journal:  Oncol Lett       Date:  2018-04-27       Impact factor: 2.967

5.  MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH.

Authors:  Wenhui Qiao; Nong Cao; Lei Yang
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

6.  MiR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1.

Authors:  Enqi Li; Jinli Zhang; Tianxiang Yuan; Baotong Ma
Journal:  Tumour Biol       Date:  2014-05-07

7.  Novel Association of miR-451 with the Incidence of TEVG Stenosis in a Murine Model.

Authors:  Narutoshi Hibino; Cameron A Best; Alyson Engle; Svetlana Ghimbovschi; Susan Knoblach; Dilip S Nath; Nobuyuki Ishibashi; Richard A Jonas
Journal:  Tissue Eng Part A       Date:  2015-12-17       Impact factor: 3.845

8.  miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2.

Authors:  Xingyu Lin; Zhiguang Yang; Peng Zhang; Yunpeng Liu; Guoguang Shao
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

9.  MiR-375 targets KLF4 and impacts the proliferation of colorectal carcinoma.

Authors:  Qiqi Mao; Tao Quan; Bin Luo; Xuefeng Guo; Lei Liu; Qinghui Zheng
Journal:  Tumour Biol       Date:  2015-07-30

10.  Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.

Authors:  Angela M Mitchell; Amy E L Stone; Linling Cheng; Kimberly Ballinger; Michael G Edwards; Mark Stoddard; Hui Li; Lucy Golden-Mason; George M Shaw; Salman Khetani; Hugo R Rosen
Journal:  MBio       Date:  2015-02-24       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.